Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Raymond

Showing results (31-40 of 173) with videos related to

Pageof 18
Sort By:
Cancer Metastasis Reviews|October 23, 2012
Targeting the Ras-ERK pathway in pancreatic adenocarcinomaCindy Neuzillet, Pascal Hammel, Annemilaï Tijeras-Raballand, et al.
Future Oncology (London, England)|February 1, 2019
Sunitinib in patients with pancreatic neuroendocrine tumors: update of safety dataJuan W Valle, Ivan Borbath, Brad Rosbrook, et al.
Bulletin Du Cancer|July 12, 2011
[PI3K-AKT-mTOR pathway and cancer]Laetitia Coutte, Chantal Dreyer, Marie-Paule Sablin, et al.
Cancer Treatment Reviews|October 7, 2014
Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumorsJuan W Valle, Sandrine Faivre, Richard A Hubner, et al.
Targeted Oncology|August 23, 2012
New treatment options with cytotoxic agents in neuroendocrine tumoursPascal Hammel, Olivia Hentic, Cindy Neuzillet, et al.
Expert Opinion on Investigational Drugs|June 24, 2010
New inhibitors of the mammalian target of rapamycin signaling pathway for cancerSébastien Albert, Maria Serova, Chantal Dreyer, et al.
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and pemetrexed: novel associations and mechanisms of resistance]Marie-Paule Sablin, Christophe Le Tourneau, Ghassan El Maalouf, et al.
Cancer Metastasis Reviews|May 22, 2013
Stromal expression of SPARC in pancreatic adenocarcinomaCindy Neuzillet, Annemilaï Tijeras-Raballand, Jérôme Cros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cellsFlorence Koeppel, Virginie Poindessous, Vladimir Lazar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2014
Resistance to human epidermal growth factor receptor type 2-targeted therapiesJean-Christophe Thery, Jean-Philippe Spano, David Azria, et al.
Pageof 18

Showing results (31-40 of 173) with videos related to

Sort By:
Pageof 18
Cancer Metastasis Reviews|October 23, 2012
Targeting the Ras-ERK pathway in pancreatic adenocarcinomaCindy Neuzillet, Pascal Hammel, Annemilaï Tijeras-Raballand, et al.
Future Oncology (London, England)|February 1, 2019
Sunitinib in patients with pancreatic neuroendocrine tumors: update of safety dataJuan W Valle, Ivan Borbath, Brad Rosbrook, et al.
Bulletin Du Cancer|July 12, 2011
[PI3K-AKT-mTOR pathway and cancer]Laetitia Coutte, Chantal Dreyer, Marie-Paule Sablin, et al.
Cancer Treatment Reviews|October 7, 2014
Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumorsJuan W Valle, Sandrine Faivre, Richard A Hubner, et al.
Targeted Oncology|August 23, 2012
New treatment options with cytotoxic agents in neuroendocrine tumoursPascal Hammel, Olivia Hentic, Cindy Neuzillet, et al.
Expert Opinion on Investigational Drugs|June 24, 2010
New inhibitors of the mammalian target of rapamycin signaling pathway for cancerSébastien Albert, Maria Serova, Chantal Dreyer, et al.
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and pemetrexed: novel associations and mechanisms of resistance]Marie-Paule Sablin, Christophe Le Tourneau, Ghassan El Maalouf, et al.
Cancer Metastasis Reviews|May 22, 2013
Stromal expression of SPARC in pancreatic adenocarcinomaCindy Neuzillet, Annemilaï Tijeras-Raballand, Jérôme Cros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cellsFlorence Koeppel, Virginie Poindessous, Vladimir Lazar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2014
Resistance to human epidermal growth factor receptor type 2-targeted therapiesJean-Christophe Thery, Jean-Philippe Spano, David Azria, et al.
Pageof 18